|
MBIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3778999999946E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.84669999997644E-06 |
| Normal-vs-Stage2 |
2.250600E-01 |
| Normal-vs-Stage3 |
1.436340E-02 |
| Normal-vs-Stage4 |
4.520200E-03 |
| Stage1-vs-Stage2 |
1.535810E-01 |
| Stage1-vs-Stage3 |
7.344100E-02 |
| Stage1-vs-Stage4 |
7.573600E-01 |
| Stage2-vs-Stage3 |
8.010200E-01 |
| Stage2-vs-Stage4 |
3.787600E-01 |
| Stage3-vs-Stage4 |
3.395000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.152260E-04 |
| Normal-vs-AfricanAmerican |
1.755270E-03 |
| Normal-vs-Asian |
4.299400E-03 |
| Caucasian-vs-AfricanAmerican |
5.987700E-02 |
| Caucasian-vs-Asian |
5.607000E-01 |
| AfricanAmerican-vs-Asian |
2.457400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.801680E-04 |
| Normal-vs-Female |
1.193360E-04 |
| Male-vs-Female |
4.098800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.76919000000053E-05 |
| Normal-vs-Age(41-60Yrs) |
5.96219999999814E-05 |
| Normal-vs-Age(61-80Yrs) |
2.337200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.712400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.829000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.956200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.125600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.838350E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.717600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.953000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.419800E-02 |
| Classical-VS-Follicular |
3.017400E-01 |
| Classical-VS-Other |
7.605200E-01 |
| Classical-VS-Normal |
1.13710000004819E-06 |
| Tall-VS-Follicular |
5.495600E-01 |
| Tall-VS-Other |
5.388600E-01 |
| Tall-VS-Normal |
1.194550E-01 |
| Follicular-VS-Other |
9.042800E-01 |
| Follicular-VS-Normal |
4.404200E-02 |
| Other-VS-Normal |
1.055750E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.280800E-03 |
| Normal-vs-N1 |
3.979900E-03 |
| N0-vs-N1 |
3.316400E-01 |
|
|
